Torrent Pharma vs Dr. Reddy’s: share price, P/E, ROE and financials compared
Torrent Pharmaceuticals
Dr. Reddy's Laboratories
Torrent Pharma and Dr. Reddy’s at a glance
Torrent Pharma and Dr. Reddy’s are both listed in Healthcare. Torrent Pharma is the larger by market cap, at ₹1.8L Cr against ₹1.1L Cr for Dr. Reddy’s (1.6 times as large). On valuation, Dr. Reddy’s has the lower P/E (40.9× against 80.2×) and the lower price-to-book (2.96× against 9.83×). On returns and margins, Torrent Pharma has the higher ROE (15.7% against 7.3%) and the higher operating margin (33.7% against 15.9%), while Dr. Reddy’s has the higher ROCE (14.2% against 9.1%). Over three years, Torrent Pharma has faster 3-year sales growth (+13.3% against +11.0% a year) and faster 3-year profit growth (+20.2% against −1.7% a year). Dr. Reddy’s carries less debt for its equity, with a debt-to-equity of 0.19× against 0.77×.
Key metrics, side by side
| Metric | Torrent PharmaTORNTPHARM | Dr. Reddy’sDRREDDY |
|---|---|---|
| Price (₹) | 4,750.00 | 1,373.00 |
| Market cap (₹ Cr) | 1,80,675 | 1,14,462 |
| P/E | 80.2× | 40.9× (the lower figure, shaded) |
| P/B | 9.83× | 2.96× (the lower figure, shaded) |
| Dividend yield, trailing | 0.80% (the higher figure, shaded) | 0.58% |
| ROE | 15.7% (the higher figure, shaded) | 7.3% |
| ROCE | 9.1% | 14.2% (the higher figure, shaded) |
| Operating margin (OPM) | 33.7% (the higher figure, shaded) | 15.9% |
| Net margin (NPM) | 12.2% (the higher figure, shaded) | 8.5% |
| Sales CAGR 3Y | +13.3% (the higher figure, shaded) | +11.0% |
| Profit CAGR 3Y | +20.2% (the higher figure, shaded) | −1.7% |
| Debt to equity | 0.77× | 0.19× (the lower figure, shaded) |
| Interest cover | 8.5× | 15.7× (the higher figure, shaded) |
| Net profit TTM (₹ Cr) | 2,124 | 2,799 |
| 1Y return | +31.7% (the higher figure, shaded) | +13.8% |
| Promoter holding | 60.78% | 26.63% |
Torrent Pharma vs Dr. Reddy’s: common questions
Which is bigger, Torrent Pharma or Dr. Reddy’s?
By market cap, Torrent Pharma is bigger at ₹1.8L Cr, against ₹1.1L Cr for Dr. Reddy’s (prices as of 6 Nov 2026). Net profit over the last twelve months was ₹2,124 Cr for Torrent Pharma and ₹2,799 Cr for Dr. Reddy’s.
Which has a lower P/E ratio, Torrent Pharma or Dr. Reddy’s?
Torrent Pharma trades at a P/E of 80.2× and Dr. Reddy’s at 40.9×. Dr. Reddy’s has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Torrent Pharma or Dr. Reddy’s?
Torrent Pharma reports a return on equity of 15.7% and Dr. Reddy’s 7.3%. Torrent Pharma has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Torrent Pharma or Dr. Reddy’s?
Over the last three years: Sales grew +13.3% a year at Torrent Pharma and +11.0% at Dr. Reddy’s, so Torrent Pharma grew sales faster; profit grew +20.2% a year at Torrent Pharma and −1.7% at Dr. Reddy’s, so Torrent Pharma grew profit faster. Past growth doesn’t predict future growth.